Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2885.00 | 3255.25 | 0.8863 | 0.7526 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 2726.00 | 3255.25 | 0.8374 | 0.6473 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 3122.00 | 3255.25 | 0.9591 | 0.9107 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3621.00 | 3255.25 | 1.1124 | 1.2470 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3219.00 | 3255.25 | 0.9889 | 0.9757 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3515.00 | 3255.25 | 1.0798 | 1.1751 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 3387.00 | 3255.25 | 1.0405 | 1.0887 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3442.00 | 3255.25 | 1.0574 | 1.1258 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3382.00 | 3255.25 | 1.0389 | 1.0853 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3509.00 | 3255.25 | 1.0780 | 1.1711 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3669.00 | 3255.25 | 1.1271 | 1.2795 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3441.00 | 3255.25 | 1.0571 | 1.1251 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3120.00 | 3255.25 | 0.9585 | 0.9093 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3243.00 | 3255.25 | 0.9962 | 0.9918 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 3674.00 | 3255.25 | 1.1286 | 1.2829 |
| SK-BR-3 | Etoposide | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3008.00 | 3255.25 | 0.9241 | 0.8345 |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 2500.00 | 1726.92 | 1442.00 | 3255.25 | 0.4430 | -0.1789 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 2500.00 | 1726.92 | 3185.00 | 3255.25 | 0.9784 | 0.9529 |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 2500.00 | 1726.92 | 1137.00 | 3255.25 | 0.3493 | -0.3668 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 2944.00 | 3255.25 | 0.9044 | 0.7919 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3244.00 | 3255.25 | 0.9965 | 0.9924 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3284.00 | 3255.25 | 1.0088 | 1.0193 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3258.00 | 3255.25 | 1.0008 | 1.0018 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5459.00 | 5536.25 | 0.9861 | 0.9640 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5283.00 | 5536.25 | 0.9543 | 0.8824 |